3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
26
Triple Negative Breast Neoplasms
6
Carcinoma, Non-Small-Cell Lung
4
Lung Neoplasms
3
Adenocarcinoma of Lung
3
Solitary Pulmonary Nodule
1
Rectal Neoplasms
1
Pain, Postoperative
1
Lymphedema
1
Carcinoma, Lobular
1
Carcinoma, Intraductal, Noninfiltrating
1
Carcinoma, Ductal, Breast
1
Carcinoma, Ductal
1
Breast Cancer Female
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Anatomic Stage II Breast Cancer AJCC v8
1
Adenocarcinoma, Bronchiolo-Alveolar
1
Interventions
Paclitaxel
7
Cyclophosphamide
6
Doxorubicin
5
pembrolizumab
3
Trastuzumab
3
Taxes
3
Specimen Handling
3
Carboplatin
3
pertuzumab
2
eribulin
2
Radiotherapy
2
Epirubicin
2
Docetaxel
2
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
ruxolitinib
1
pegfilgrastim
1
onvansertib
1
olaparib
1
neratinib
1
durvalumab
1
cobimetinib
1
atezolizumab
1
X-Rays
1
Therapeutics
1
Tamoxifen
1
Surgical Procedures, Operative
1
Radiation
1
Peripheral Blood Stem Cell Transplantation
1
Panitumumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Inflammatory Breast Neoplasms
×
Mastectomy, Segmental
×
1 year
×
Clear all
No trials found.